Inari Ebitda vs Income Tax Expense Analysis
NARI Stock | USD 48.40 1.30 2.76% |
Inari Medical financial indicator trend analysis is infinitely more than just investigating Inari Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inari Medical is a good investment. Please check the relationship between Inari Medical Ebitda and its Income Tax Expense accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
Ebitda vs Income Tax Expense
Ebitda vs Income Tax Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inari Medical Ebitda account and Income Tax Expense. At this time, the significance of the direction appears to have very week relationship.
The correlation between Inari Medical's Ebitda and Income Tax Expense is 0.27. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Inari Medical, assuming nothing else is changed. The correlation between historical values of Inari Medical's Ebitda and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Inari Medical are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Ebitda i.e., Inari Medical's Ebitda and Income Tax Expense go up and down completely randomly.
Correlation Coefficient | 0.27 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Ebitda
Income Tax Expense
Most indicators from Inari Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inari Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.As of now, Inari Medical's Tax Provision is increasing as compared to previous years. The Inari Medical's current Sales General And Administrative To Revenue is estimated to increase to 0.94, while Selling General Administrative is projected to decrease to under 176.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 4.5M | 7.6M | 10.7M | 11.3M | Interest Income | 154K | 1.9M | 15.6M | 16.4M |
Inari Medical fundamental ratios Correlations
Click cells to compare fundamentals
Inari Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Inari Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 44.5M | 214.1M | 311.5M | 504.2M | 674.2M | 707.9M | |
Other Current Liab | 6.3M | 10.8M | 35.2M | 47.2M | 64.1M | 67.3M | |
Total Current Liabilities | 8.9M | 13.8M | 42.5M | 56.2M | 76.3M | 80.2M | |
Total Stockholder Equity | (39.1M) | 200.3M | 239.2M | 417.0M | 464.9M | 488.2M | |
Net Tangible Assets | (39.1M) | 200.3M | 239.2M | 417.0M | 479.6M | 503.5M | |
Property Plant And Equipment Net | 3.3M | 7.5M | 61.4M | 72.4M | 69.3M | 39.4M | |
Net Debt | (4.2M) | (114.2M) | (63.5M) | (27.9M) | (7.2M) | (7.5M) | |
Retained Earnings | (41.2M) | (27.4M) | (17.6M) | (46.9M) | (48.5M) | (50.9M) | |
Accounts Payable | 2.5M | 3.0M | 6.5M | 7.7M | 10.6M | 5.7M | |
Cash | 23.6M | 114.2M | 92.8M | 60.2M | 39.2M | 64.5M | |
Non Current Assets Total | 5.1M | 8.4M | 66.3M | 81.2M | 438.7M | 460.6M | |
Non Currrent Assets Other | 1.5M | 583K | 981K | 589K | 2.2M | 2.3M | |
Other Assets | 1.8M | 921K | 981K | 589K | 677.4K | 949.3K | |
Cash And Short Term Investments | 23.6M | 164.2M | 176.1M | 326.4M | 116.1M | 151.8M | |
Net Receivables | 11.3M | 28.0M | 42.4M | 58.6M | 70.1M | 39.0M | |
Common Stock Shares Outstanding | 48.2M | 51.6M | 55.6M | 52.8M | 56.8M | 56.8M | |
Liabilities And Stockholders Equity | 44.5M | 214.1M | 311.5M | 504.2M | 674.2M | 707.9M | |
Non Current Liabilities Total | 74.8M | 3.0M | 29.8M | 31.0M | 133.0M | 139.6M | |
Inventory | 4.0M | 10.6M | 21.1M | 32.6M | 42.9M | 45.0M | |
Other Current Assets | 514.1K | 2.9M | 5.7M | 5.3M | 6.5M | 4.0M | |
Other Stockholder Equity | 2.1M | 227.6M | 257.1M | 462.9M | 504.5M | 266.9M | |
Total Liab | 83.7M | 13.8M | 72.3M | 87.2M | 209.3M | 219.8M | |
Net Invested Capital | (19.7M) | 200.3M | 239.2M | 417.0M | 464.9M | 233.2M | |
Property Plant And Equipment Gross | 3.3M | 7.5M | 61.4M | 72.4M | 83.0M | 41.9M | |
Total Current Assets | 39.4M | 205.7M | 245.2M | 422.9M | 235.6M | 215.4M | |
Accumulated Other Comprehensive Income | (54.2M) | 4K | (402K) | 849K | 8.9M | 9.3M | |
Capital Stock | 6.7K | 49K | 50K | 54K | 58K | 41.1K | |
Net Working Capital | 30.5M | 191.8M | 202.7M | 366.7M | 159.2M | 178.7M | |
Common Stock | 6.7K | 49K | 50K | 54K | 58K | 41.1K | |
Property Plant Equipment | 3.3M | 7.5M | 16.5M | 72.4M | 83.2M | 87.4M |
Currently Active Assets on Macroaxis
When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (1.29) | Revenue Per Share 9.901 | Quarterly Revenue Growth 0.214 | Return On Assets (0.03) |
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.